Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth W Kinzler

Showing results (141-150 of 282) with videos related to

Pageof 29
Sort By:
Science (New York, N.Y.)|March 16, 2004
High frequency of mutations of the PIK3CA gene in human cancersYardena Samuels, Zhenghe Wang, Alberto Bardelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2004
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patientsTian-Li Wang, Luis A Diaz, Katharine Romans, et al.
Molecular Cancer Research : MCR|April 21, 2012
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypesMelinda D Willard, Mary E Lajiness, Isabella H Wulur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancersJens Koopmann, Phillip Buckhaults, David A Brown, et al.
Science (New York, N.Y.)|December 7, 2013
Association of the autoimmune disease scleroderma with an immunologic response to cancerChristine G Joseph, Erika Darrah, Ami A Shah, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2014
A diaCEST MRI approach for monitoring liposomal accumulation in tumorsKannie W Y Chan, Tao Yu, Yuan Qiao, et al.
Nature|August 12, 2005
Colorectal cancer: mutations in a signalling pathwayD Williams Parsons, Tian-Li Wang, Yardena Samuels, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 25, 2016
Aristolochic Acid in the Etiology of Renal Cell CarcinomaMargaret L Hoang, Chung-Hsin Chen, Pau-Chung Chen, et al.
Elife|May 20, 2025
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Science (New York, N.Y.)|August 8, 2009
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsJihye Yun, Carlo Rago, Ian Cheong, et al.
Pageof 29

Showing results (141-150 of 282) with videos related to

Sort By:
Pageof 29
Science (New York, N.Y.)|March 16, 2004
High frequency of mutations of the PIK3CA gene in human cancersYardena Samuels, Zhenghe Wang, Alberto Bardelli, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 19, 2004
Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patientsTian-Li Wang, Luis A Diaz, Katharine Romans, et al.
Molecular Cancer Research : MCR|April 21, 2012
Somatic mutations in CCK2R alter receptor activity that promote oncogenic phenotypesMelinda D Willard, Mary E Lajiness, Isabella H Wulur, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 10, 2004
Serum macrophage inhibitory cytokine 1 as a marker of pancreatic and other periampullary cancersJens Koopmann, Phillip Buckhaults, David A Brown, et al.
Science (New York, N.Y.)|December 7, 2013
Association of the autoimmune disease scleroderma with an immunologic response to cancerChristine G Joseph, Erika Darrah, Ami A Shah, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|February 20, 2014
A diaCEST MRI approach for monitoring liposomal accumulation in tumorsKannie W Y Chan, Tao Yu, Yuan Qiao, et al.
Nature|August 12, 2005
Colorectal cancer: mutations in a signalling pathwayD Williams Parsons, Tian-Li Wang, Yardena Samuels, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|August 25, 2016
Aristolochic Acid in the Etiology of Renal Cell CarcinomaMargaret L Hoang, Chung-Hsin Chen, Pau-Chung Chen, et al.
Elife|May 20, 2025
ME3BP-7 is a targeted cytotoxic agent that rapidly kills pancreatic cancer cells expressing high levels of monocarboxylate transporter MCT1Jordina Rincon-Torroella, Marco Dal Molin, Brian Mog, et al.
Science (New York, N.Y.)|August 8, 2009
Glucose deprivation contributes to the development of KRAS pathway mutations in tumor cellsJihye Yun, Carlo Rago, Ian Cheong, et al.
Pageof 29